CQS New City High Yield Fund Revenue
What is the Revenue of CQS New City High Yield Fund?
The Revenue of CQS New City High Yield Fund Ltd. is £8.238M
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Finance sector on LSE compared to CQS New City High Yield Fund
What does CQS New City High Yield Fund do?
CQS New City High Yield Fund Limited is a close ended fixed income mutual fund launched by CQS Asset Management Ltd. The fund is managed by CQS (UK) LLP. It invests in fixed income markets. The fund primarily invests in fixed income securities such as corporate and government bonds, loan stocks, and high yielding bonds. It uses a value approach to create its portfolio. The fund was formerly known as New City High Yield Fund Limited. CQS New City High Yield Fund Limited was formed in October 2004 and is domiciled in the Channel Islands.
Companies with revenue similar to CQS New City High Yield Fund
- Spectur has Revenue of AUD$8.180M
- Ocugen Inc has Revenue of $8.191M
- Safe & Green Corp has Revenue of $8.193M
- Timah Resources has Revenue of RM8.200M
- cyan AG has Revenue of €8.200M
- Mereo BioPharma plc has Revenue of £8.231M
- CQS New City High Yield Fund has Revenue of £8.238M
- InCity Immobilien AG has Revenue of €8.275M
- Ariadne Australia has Revenue of AUD$8.280M
- Dev Clever Plc has Revenue of £8.284M
- Cue Biopharma Inc has Revenue of $8.296M
- Celldex Therapeutics has Revenue of $8.302M
- RAS Technology Ltd has Revenue of AUD$8.328M